Is a Type 1 Diabetes Cure Right Around the Corner?

For lack of a better phrase, those who have type 1 diabetes -- a form of diabetes whereby the person's own autoimmune system attacks or attempts to destroy cells in the pancreas responsible for producing insulin -- often get the short end of the stick.

Despite being the most common chronic disease in children, type 1 diabetes accounts for just 5% of all diabetes diagnoses. The remaining 95% are type 2 diabetics who see their glycemic imbalance brought upon because of a number of factors including genetic make-up, and a number of behavioral habits like smoking or obesity caused by poor diet or lack or exercise. With the pendulum swinging so decisively toward type 2 diabetes in number of diagnoses, it's not surprising to see so many pharmaceutical companies focusing their efforts on developing new type 2 medications.

That pendulum, though, may be ready to swing back in the other direction.

In one of the more exciting studies I've witnessed over the past few years, a research team at Boston Children's Hospital released its findings via a blog post last week that it had discovered the pathway responsible for causing type 1 diabetes. After testing hundreds of different pathways in animals, researchers, identified the ATP/P2X7R pathway as the one responsible for triggering T-cell attacks on the pancreas that render it incapable of producing insulin.

It's all about treating the symptoms

Source: Sarah G., Flickr.

As of right now, the primary treatment option associated with type 1 diabetes is insulin, as well as maintaining a healthy lifestyle through proper diet and exercise. Insulin comes in various forms, from the rapid-acting type to longer-lasting insulins.

Eli Lilly's (NYSE: LLY  ) Humalog, for example, is one of the most widely used rapidly acting insulins. Its duration time is only three to five hours, but it'll peak in effectiveness in as little as 30 minutes. It was also responsible for $2.4 billion, or 11%, of Eli Lilly's total pharmaceutical sales last year and works well if taken while a meal is being consumed.

On the other end of the spectrum is Sanofi's (NYSE: SNY  ) Lantus, which is a once-daily injection that can work in the body for up to 20-24 hours, but can also be combined with a short-acting insulin if needed. Lantus has been an absolute blockbuster diabetes drug up until now, garnering worldwide sales of more than $6 billion in 2012.

Another big beneficiary from type 1 diabetes is glucose-monitoring device makers. Perhaps the most exciting product in this space is Bayer's (NASDAQOTH: BAYRY  ) Contour Next Link. Bayer has partnered its device with Medtronic (NYSE: MDT  ) in such a way that it'll connect wirelessly to Medtronic's insulin pump, drastically reducing many instances of human error or forgetfulness, and delivering the right dosage of insulin to patients throughout the course of the day.

Soon, we may be curing the disease
But, the truth of the matter is that these are treatments for the symptoms associated with type 1 diabetes; they aren't cures. The research conducted at Boston Children's Hospital offers the possibility of an actual cure if a medication can be developed that suppresses autoimmune dysfunction based on this specific pathway. Admittedly, we could be looking at half a decade or longer before there's a big enough human trial to validate whether a cure can be derived, but this is exciting news nonetheless.

It would also make a lot of sense for a company like Eli Lilly or Sanofi to lead the way in terms of type 1 diabetes research, as Lilly's Humalog is set to lose patent protection next year and Sanofi's patents will expire in 2014/2015. These two pharmaceutical giants would love to replace the revenue that's almost certain to be lost because of generic competition. Building upon Boston Children Hospital's research could be one way of accomplishing this.

While we're still quite a ways from a cure, type 1 diabetes patients certainly have a reason to be a little more hopeful as it appears researchers are now one step closer.

With two of its top three drugs poised to lose patent protection this year, is Eli Lilly a dividend stock headed nowhere fast? In a new premium report, The Motley Fool's senior pharmaceuticals analyst breaks down all of Lilly's moving parts, including an in-depth analysis of the company's must-know opportunities and reasons to buy and sell today. To find out more click here to claim your copy today.

Read/Post Comments (3) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 19, 2013, at 8:17 PM, Makikijoe wrote:

    Let's pray for a miracle in diabetes research.

    God can make it happen.

    Prayer is powerful.

  • Report this Comment On January 14, 2014, at 9:45 AM, gerogea wrote:

    Scientifically Proven Principles That Will Have Your Body Producing More Insulin Naturally (Check it here:

    Are you sick and tired of constantly...

    -worrying about all the long-term diabetes complications...

    -sticking your fingers with needles and testing your blood sugar…

    -facing an 80% risk of dying from heart disease or stroke...

    -Feeling guilty about food and your weight…

    -being concerned with not being able to lose weight, which the medicine seems to -put on and keep on…

    -being overwhelmed by the daily care and vigilance the disease requires…

    -dealing with the “side-effects” of your medications...

    If you are sick and tired of being Sick and Tired while you suffer from this entirely curable condition, then this will be the most important letter you'll ever read.

    The Diabetes Cure We So Desperately Need Is Here:

  • Report this Comment On June 24, 2014, at 6:35 PM, katemorrison22 wrote:

    I am so very happy to share this great testimony about a powerful spell caster DR OVIA who rescue me from this deadly disease(Alzheimer's disease and diabetes type 1), I am Crystal Conner from United states, i was once suffering from Alzheimer's disease and diabetes and i tried my possible best to get cured but all seems in vain, So all through this period of my life, i was unhappy until the very day i came across the testimony of a lady on a blogger testifying how she was helped by DR OVIA in curing her HIV and she also mentioned that this same man can equally healed and cure any sickness with his herbal medicine, So without any doubt, i contacted him on his email which is and i explained my problems to him, without wasting time, he told me that he is going to help me and did an herbal medicine for me which he sent to me and he told me to using it according to the instruction that i will see on it, so i abide to him, before i know it, i was beginning to feel some changes in me and i went for medical check up and to my surprise, i was healed and cured from the disease, I am so very happy now as i am sharing this testimony and i want to use this medium to tell anyone who is passing through this Alzheimer's or diabetes or any kind of disease like HIV AIDS, Cancer, syphilis, hepatietis kidney problem, gall stone and lot's more should qucikly contact DR OVIA on his email: or call him through his mobile number +2347067610698. His Herbal medicine is one of a kind and i believe he can also cure you too just as he has cured me..


Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2495679, ~/Articles/ArticleHandler.aspx, 9/28/2016 1:36:53 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:01 PM
LLY $80.88 Up +1.36 +1.71%
Eli Lilly and Co. CAPS Rating: ***
SNY $38.15 Up +0.11 +0.29%
Sanofi CAPS Rating: *****
BAYRY $99.71 Down -0.82 -0.81%
Bayer AG (ADR) CAPS Rating: ***
MDT $86.67 Up +0.54 +0.63%
Medtronic CAPS Rating: *****